Volume 24, Issue 10
Short Communication

Reproducibility of neurophysiological and myometric measurement in the ulnar nerve–abductor digiti minimi system

Mamede de Carvalho MD

Department of Neurology, Hospital de Santa Maria, EMG Laboratory of Centro de Estudos Egas Moniz, Lisbon, Portugal

Search for more papers by this author
Arminda Lopes MD

Hospital of Medical Rehabilitation of Alcoitão, Estoril, Portugal

Search for more papers by this author
Manuel Scotto PhD

Department of Mathematics, University of Aveiro, Aveiro, Portugal

Search for more papers by this author
Michael Swash MD

Corresponding Author

E-mail address: mswash@btinternet.com

Department of Neurology, The Royal London Hospital, London E1 1BB, United Kingdom

Department of Neurology, The Royal London Hospital, London E1 1BB, United KingdomSearch for more papers by this author
First published: 13 September 2001
Citations: 21

Abstract

Reliability in strength and neurophysiological measurements is important in evaluating progression of neuromuscular diseases. No data are available on the variability of neurophysiological parameters as compared with maximal voluntary isometric contraction (MVIC) in the same muscles, in healthy subjects. A control population of 26 healthy subjects was studied twice on different days. We evaluated the reliability of neurophysiological parameters obtained from bilateral ulnar nerve stimulation, recording the response over the abductor digiti minimi (ADM) muscle, including distal motor latency, compound muscle potential amplitude and area, F‐wave frequency and mean F‐wave latency, and the derived neurophysiological index that we have described previously. MVIC force was measured in each session in both ADM muscles. The variances between the grouped data obtained in the two recording sessions were identical, indicating a low intrinsic variability with this experimental methodology. Comparison of the mean values obtained in the two sessions revealed no statistically significant differences. The reliability of these neurophysiological and strength measurements in the same nerve/muscle system suggests they may be useful in comparing the dynamics of weakness and neurophysiological change in neuromuscular disease. © 2001 John Wiley & Sons, Inc. Muscle Nerve 24: 1391–1395, 2001

Number of times cited according to CrossRef: 21

  • Parameters derived from compound muscle action potential scan for discriminating amyotrophic lateral sclerosis‐related denervation, Muscle & Nerve, 10.1002/mus.26644, 60, 4, (400-408), (2019).
  • Beyond fractional anisotropy in amyotrophic lateral sclerosis: the value of mean, axial, and radial diffusivity and its correlation with electrophysiological conductivity changes, Neuroradiology, 10.1007/s00234-018-2012-6, 60, 5, (505-515), (2018).
  • Ulnar Nerve Conduction Block Using Surface Kilohertz Frequency Alternating Current: A Feasibility Study, Artificial Organs, 10.1111/aor.13119, 42, 8, (841-846), (2018).
  • Nerve Conduction Studies as a Measure of Disease Progression: Objectivity or Illusion?, Journal of Neuromuscular Diseases, 10.3233/JND-170243, 4, 3, (209-215), (2017).
  • Split-hand to diagnosis shot, Clinical Neurophysiology, 10.1016/j.clinph.2012.08.015, 124, 2, (219-220), (2013).
  • Neurophysiological approach to disorders of peripheral nerve, Peripheral Nerve Disorders, 10.1016/B978-0-444-52902-2.00006-0, (81-114), (2013).
  • Neurophysiological index as a biomarker for ALS progression: Validity of mixed effects models, Amyotrophic Lateral Sclerosis, 10.3109/17482968.2010.531742, 12, 1, (33-38), (2011).
  • Clinical patterns in progressive muscular atrophy (PMA): A prospective study, Amyotrophic Lateral Sclerosis, 10.1080/17482960701452902, 8, 5, (296-299), (2009).
  • Neurophysiological measures in amyotrophic lateral sclerosis: Markers of progression in clinical trials, Amyotrophic Lateral Sclerosis, 10.1080/14660820410020600, 6, 1, (17-28), (2009).
  • Reliability of techniques to assess human neuromuscular function in vivo, Journal of Electromyography and Kinesiology, 10.1016/j.jelekin.2005.11.008, 17, 1, (90-101), (2007).
  • Quels sont les critères électro-neuro-myographiques requis pour le diagnostic de SLA ?, Revue Neurologique, 10.1016/S0035-3787(06)75164-5, 162, (43-49), (2006).
  • Does caffeine modify corticomotor excitability?, Neurophysiologie Clinique/Clinical Neurophysiology, 10.1016/j.neucli.2006.08.005, 36, 4, (219-226), (2006).
  • Évaluation des fonctions motrices dans la sclérose latérale amyotrophique (SLA), Revue Neurologique, 10.1016/S0035-3787(06)75177-3, 162, (138-144), (2006).
  • Tools, Atlas of Neuromuscular Diseases, 10.1007/b138110, (5-30), (2005).
  • The role of clinical neurophysiology inmotor neuron diseases: where next?, Clinical Neurophysiology of Motor Neuron Diseases, 10.1016/S1567-4231(04)04041-9, (701-711), (2004).
  • Analysis of force profile during a maximum voluntary isometric contraction task, Muscle & Nerve, 10.1002/mus.10564, 29, 3, (401-408), (2004).
  • Motor responses evoked by transcranial magnetic stimulation and peripheral nerve stimulation in the ulnar innervation in amyotrophic lateral sclerosis: the effect of upper and lower motor neuron lesion, Journal of the Neurological Sciences, 10.1016/S0022-510X(03)00024-8, 210, 1-2, (83-90), (2003).
  • Chapter 3 Neurophysiological Investigation of Motor Neuron Disorders, Motor Neuron Disorders, 10.1016/S1877-3419(09)70104-7, (51-72), (2003).
  • Clinical and neurophysiological evaluation of progression in amyotrophic lateral sclerosis, Muscle & Nerve, 10.1002/mus.10469, 28, 5, (630-633), (2003).
  • What does the neurologist expect from clinical neurophysiology?, Muscle & Nerve, 10.1002/mus.10155, 25, S11, (S134-S138), (2002).
  • Clinical neurophysiology of ALS, Clinical Neurophysiology, 10.1016/S1388-2457(01)00692-7, 112, 12, (2190-2201), (2001).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me